TRU-SENTIMENT · DeltaNeutral
NBIX Trading Analysis - 09/24/2026 03:03 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
NBIX (Neurocrine Biosciences Inc) at $139.88. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $1,280 vs put $0. RSI 17.9.
- Symbol
- NBIX
- Price
- $139.88
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-09-24 15:03:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Bullish
Call vs Put dollar volume analysis: 100% call volume, indicating strong bullish conviction.
Key Statistics: NBIX
Fundamental Snapshot
Valuation
| P/E (Trailing) | 20.45 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 7.81 |
Profitability
| EPS (Trailing) | $6.82 |
| EPS (Forward) | N/A |
| ROE | 19.10% |
| Net Margin | 20.91% |
Financial Health
| Revenue (TTM) | $3.37B |
| Debt/Equity | 0.45 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for NBIX include:
- Neurocrine Biosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Update
- Neurocrine Biosciences' Ingrezza Continues to Show Positive Results in Clinical Trials
- Neurocrine Biosciences Receives FDA Approval for New Indication for Ingrezza
These headlines suggest that NBIX has been experiencing positive developments in their clinical trials and product offerings, which could be contributing to the current market sentiment.
Fundamental Analysis:
Based on the provided fundamentals data:
- Revenue: $3,373,900,000
- Trailing EPS: $6.82
- Trailing P/E: 20.45
- Debt/Equity: 0.45
- ROE: 19.10%
The company's revenue and EPS suggest a stable financial position. The P/E ratio indicates that the stock may be fairly valued. The debt/equity ratio and ROE suggest a healthy balance sheet and profitability.
Current Market Position:
Current price: $139.89
Recent price action: The stock has been trending downward in the short term, with a recent low of $137.00 and a high of $140.63.
Technical Analysis:
Technical Indicators
The RSI indicates that the stock is oversold, with a value below 20. The MACD suggests a bearish trend, with a negative value. The 50-day SMA indicates that the stock is currently below its medium-term average price.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Bullish
Call vs Put dollar volume analysis: 100% call volume, indicating strong bullish conviction.
Key Price Levels (observational only):
25-Day Price Forecast:
Based on current trends and indicators, NBIX is projected for $140.00 to $150.00 over the next 25 days.
The forecast is based on the current oversold RSI, bullish MACD divergence, and support levels.
Defined Risk Strategy Recommendations:
Based on the price forecast, consider the following defined risk strategies:
- Buy Bull Call Spread: NBIX 261016C00140000 (strike $140.0) and sell NBIX 261016C00150000 (strike $150.0)
- Sell Bear Put Spread: NBIX 261016P00135000 (strike $135.0) and buy NBIX 261016P00140000 (strike $140.0)
- Buy Iron Condor: NBIX 261016P00130000 (strike $130.0), sell NBIX 261016P00135000 (strike $135.0), sell NBIX 261016C00145000 (strike $145.0), and buy NBIX 261016C00150000 (strike $150.0)
Risk Factors:
- Technical warning signs: oversold RSI and bearish MACD
- Sentiment divergences: bullish options flow vs bearish technicals
- Volatility and ATR considerations: high volatility could impact strategy performance
Summary & Conviction Level:
Overall bias: Bullish
Conviction level: Medium
One-line trade idea: Consider buying NBIX calls or Bull Call Spreads to capitalize on potential rebound.
View NBIX Options Chain